| Net income | -226K |
| Amortization of intangible assets | 5.25M |
| Depreciation and amortization of property and equipment | |
| Accretion of discount and issuance costs on notes | |
| Net recovery of sales allowances | |
| Share-based compensation | 16.99M |
| Loss on revaluation of contingent consideration | |
| Deferred income taxes | -4.45M |
| Excess tax benefits from share-based compensation | |
| Loss from equity method investments | |
| Accounts receivable | -9.35M |
| Deferred costs and other assets | |
| Accounts payable | 1.34M |
| Accrued liabilities | 5.98M |
| Deferred revenues | 10.32M |
| Net cash provided by operating activities | 25.47M |
| Purchases of investments | |
| Maturities of investments | |
| Increase(decrease) in customer funding liabilities, net of changes in restricted cash | |
| Investments in unconsolidated affiliates | -1.75M |
| Investments in consolidated joint venture by noncontrolling interest | |
| Acquisition funds held at trust | |
| Purchases of property and equipment | |
| Payments for acquisitions, net of cash acquired | -1.25M |
| Net cash provided by (used in) investing activities | 126.73M |
| Proceeds from borrowings on senior convertible notes | 0 |
| Equity issuance costs | 0 |
| Net proceeds from share-based equity award activity | |
| Proceeds from employee stock purchase plan activity | |
| Tax withholding on share-based awards | -3K |
| Excess tax benefits from share-based compensation | 31K |
| Repayments on capital leases | |
| Net cash provided by (used in) financing activities | -1.21M |
| Effect of foreign currency exchange rate changes on cash and cash equivalents | 780K |
| Net increase (decrease) in cash and cash equivalents | 151.77M |
| Cash and cash equivalents at beginning of period | 323.26M |
| Cash and cash equivalents at end of period | 475.03M |
| Cash paid for interest | |
| Income tax (receipts) payments, net | 1.08M |